Group 1 - The core point of the news is that Suochen Technology (688507.SH) is currently experiencing a decline in stock price, with a closing price of 98.30 yuan and a drop of 2.87%, resulting in a total market value of 8.759 billion yuan [1] - Suochen Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 18, 2023, with an issuance of 10.3334 million shares at a price of 245.56 yuan per share [1] - The company raised a total of 253.74697 million yuan through its initial public offering (IPO), with a net amount of 231.57491 million yuan, exceeding the original plan by 134.68455 million yuan [1] Group 2 - The funds raised are intended for various projects, including the construction of a research and development center, an industrial simulation cloud project, the construction of 260 underwater noise testing instruments, marketing network development, and to supplement working capital [1] - The total issuance costs for the IPO amounted to 22.17206 million yuan (excluding tax), with underwriting fees accounting for 19.23102 million yuan [1] - In the 2022 annual profit distribution, the company distributed a cash dividend of 0.15 yuan per share and increased its capital by 0.48 shares per share, resulting in a total of 6.20001 million yuan in cash dividends and 19.840032 million shares being transferred [2]

Core Viewpoint - The announcement highlights a significant change in the equity holdings of Youyan Silicon, with its controlling shareholder and concerted parties reducing their stake by 1% [1] Group 1: Shareholding Changes - On February 11, 2026, Youyan Silicon's controlling shareholder RS Technologies and its concerted party, Cangyuan Investment, reduced their holdings by a total of 2,362.55 million shares, representing a decrease from 59.19% to 57.30% of total shares [1] - Cangyuan Investment sold 10 million shares through centralized bidding, accounting for 0.80% of the total shares, while RS Technologies and Cangyuan Investment sold 13.6255 million shares through block trading, accounting for 1.09% of total shares [1] Group 2: Financial Performance - In 2023, Youyan Silicon reported total revenue of 960.40 million yuan, a year-on-year decrease of 18.29%, and a net profit attributable to shareholders of 254.18 million yuan, down 27.65% [2] - The company’s net profit after deducting non-recurring gains and losses was 165.00 million yuan, reflecting a significant decline of 47.28% year-on-year [2] - For 2024, total revenue increased to 995.95 million yuan, a growth of 3.70%, but net profit decreased by 8.37% to 232.90 million yuan [3] - In 2025, total revenue was reported at 1,005.25 million yuan, a slight increase of 0.93%, while net profit fell by 10.14% to 209.28 million yuan [3] Group 3: Initial Public Offering (IPO) Details - Youyan Silicon was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 10, 2022, with an initial issuance of 187,143,158 shares at a price of 9.91 yuan per share [2] - The total funds raised from the IPO amounted to 1,854.59 million yuan, with a net amount of 1,663.97 million yuan after deducting issuance costs [2] - The company planned to use the raised funds for projects related to 8-inch silicon wafer expansion, silicon materials for integrated circuit etching equipment, and to supplement R&D and operational funds [2]

Group 1 - The core point of the article is that Suochen Technology (688507.SH) is currently experiencing a decline in stock price, with a closing price of 96.93 yuan and a drop of 2.14%, indicating a state of being below its initial public offering (IPO) price [1] - Suochen Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 18, 2023, with an issuance of 10,333,400 shares at an IPO price of 245.56 yuan per share [1] - The total funds raised from the IPO amounted to 253,746.97 million yuan, with a net amount of 231,574.91 million yuan, exceeding the original plan by 134,684.55 million yuan [1] Group 2 - The total issuance costs for Suochen Technology's IPO were 22,172.06 million yuan (excluding tax), with underwriting fees accounting for 19,231.02 million yuan [2] - The company announced a cash dividend of 0.15 yuan per share (including tax) and a capital reserve increase of 0.48 shares for every share held, resulting in a total distribution of 6,200,010 yuan in cash dividends and an increase of 19,840,032 shares, raising the total share capital to 61,173,432 shares [2] - For the 2023 annual profit distribution, the company plans to distribute a cash dividend of 3.80 yuan for every 10 shares (including tax) and a capital reserve increase of 4.60 shares for every 10 shares, with the record date set for June 18, 2024 [2]

Financial Performance - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -102 million RMB and -147 million RMB, indicating a reduction in losses by 143.6 million RMB to 188.6 million RMB compared to the previous year, representing a year-on-year loss reduction of 49% to 65% [1] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -106 million RMB and -151 million RMB, with a loss reduction of 149.2 million RMB to 194.2 million RMB compared to the previous year, also reflecting a year-on-year loss reduction of 50% to 65% [1] - The company's operating revenues for 2022, 2023, and 2024 were 559 million RMB, 394 million RMB, and 546 million RMB respectively, with net profits attributable to shareholders of -15.15 million RMB, -54.18 million RMB, and -291 million RMB for the same years [1] IPO and Fundraising - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 21, 2022, with an initial public offering of 40.01 million shares, accounting for 10% of the total shares post-IPO, at a price of 33.57 RMB per share [2] - On the first day of trading, the stock reached a maximum price of 51.88 RMB, but is currently in a state of decline [3] - The total funds raised from the IPO amounted to 1.343 billion RMB, with a net amount of 1.221 billion RMB after deducting issuance costs, exceeding the original plan by 640 million RMB [3] Use of Proceeds - The company plans to use the raised funds for the research and industrialization of high-performance power management chips for consumer electronics and communication devices, the development of next-generation automotive and industrial power management chips, the establishment of a headquarters base, and for working capital [3] Underwriters and Shareholding - The total issuance costs amounted to 122 million RMB, with underwriting and sponsorship fees of 102 million RMB received by the underwriters [4] - The joint lead underwriters, including Guolian Minsheng Securities and China International Capital Corporation, received allocations of 1.6004 million shares each, representing 4% of the total shares issued [4]

Core Viewpoint - Foxit Software (688095.SH) has experienced a significant decline in stock price, closing at 96.09 yuan with a drop of 7.37% on February 4, 2023, indicating a current state of underperformance since its IPO [1] Group 1: IPO and Financial Performance - Foxit Software was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 8, 2020, with an issuance of 12.04 million shares at a price of 238.53 yuan per share [1] - The company raised a total of 2.872 billion yuan through its initial public offering (IPO), with a net amount of 2.586 billion yuan after deducting issuance costs [1] - The final net fundraising amount exceeded the original plan by 2.179 billion yuan, with the initial plan set at 407 million yuan for various projects [1] Group 2: Stock Performance and Dividends - The stock reached its highest price of 373.00 yuan within nine trading days post-IPO but is currently in a state of decline [1] - The company announced a cash dividend of 0.8 yuan per share (tax included) and a stock bonus of 0.4 shares per share for the 2021 fiscal year, with the record date on June 27, 2022 [3] - For the 2022 fiscal year, Foxit Software proposed a cash dividend of 0.5 yuan per share (tax included) and a stock bonus of 0.4 shares per share, with the record date on June 20, 2023 [3] Group 3: Strategic Investors - The strategic placement for Foxit Software included 361,200 shares allocated to Xingzheng Investment Management Co., with a total investment of 86.157 million yuan, representing 3% of the total issuance [2]

Core Viewpoint - The company Kalete (301391.SZ) announced a share reduction plan by its major shareholder Shenzhen Nabai Chuan Innovation Enterprise (Limited Partnership), which aims to sell up to 2,763,226 shares due to funding needs [1] Group 1: Share Reduction Plan - Shenzhen Nabai Chuan plans to reduce its holdings in Kalete by up to 921,075 shares through centralized bidding and up to 1,842,151 shares through block trading within three months after the announcement [1] - The total expected reduction amounts to 2,763,226 shares, representing approximately 3.00% of the total share capital after excluding shares held in the company's repurchase account [1] - As of January 21, 2026, the last trading day before the announcement, Kalete's share price was 78.77 yuan, leading to an estimated reduction amount of 21,765.93 million yuan [1] Group 2: Financial Performance - For the first nine months of 2024 and 2025, Kalete reported net profits attributable to shareholders of 19.35 million yuan and 13.38 million yuan, respectively [2] - The net profit after deducting non-recurring gains and losses was -22.19 million yuan for 2024 and -13.01 million yuan for 2025 [2] - Kalete went public on December 1, 2022, raising a total of 163.20 million yuan, with a net amount of 145.53 million yuan after expenses [2] Group 3: Dividend Distribution - Kalete's annual equity distribution plan for 2023 includes a cash dividend of 8 yuan per 10 shares and a capital reserve conversion of 4 additional shares for every 10 shares held [3] - The record date for this equity distribution is set for May 29, 2024, with the ex-dividend date on May 30, 2024 [3]

Group 1 - The core point of the news is that the controlling shareholder RS Technologies and its action-in-concert party, Fujian Cangyuan Investment Co., plan to reduce their holdings in Youyan Silicon by a total of up to 37,500,000 shares, which is no more than 3% of the company's total share capital [1] - RS Technologies intends to reduce its holdings by up to 12,500,000 shares through block trading, accounting for no more than 1% of the total share capital, while Cangyuan Investment plans to reduce its holdings by up to 25,000,000 shares through centralized bidding and block trading, accounting for no more than 2% of the total share capital [1] - The reduction is due to the operational funding needs of the shareholders, and there are specific regulations regarding the maximum number of shares that can be sold within a 90-day period [1] Group 2 - Based on the closing price of 14.47 yuan on January 16, the total amount from the share reduction is approximately 543 million yuan [2] - Youyan Silicon was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 10, 2022, with an initial issuance of 187,143,158 shares at a price of 9.91 yuan per share, raising a total of 1.85 billion yuan [2] - The net amount raised after deducting issuance costs was approximately 1.66 billion yuan, which was 663.97 million yuan more than the original plan of 1 billion yuan [2] Group 3 - In 2023, Youyan Silicon reported operating revenue of 960.40 million yuan, a year-on-year decrease of 18.29%, and a net profit attributable to shareholders of 254.18 million yuan, down 27.65% [3] - For 2024, the company achieved total operating revenue of 995.95 million yuan, a year-on-year increase of 3.70%, but the net profit attributable to the parent company decreased by 8.37% to 232.90 million yuan [3] - The net profit excluding non-recurring gains and losses for 2024 was 163.02 million yuan, showing a slight decline of 1.20% [3]

Group 1 - The core point of the news is that Chen Chaohui, a shareholder and senior executive of Ruina Intelligent, plans to reduce his shareholding by selling up to 279,500 shares, which is approximately 0.21% of the company's total equity [1] - Ruina Intelligent's total share capital is 136,000,000 shares, and Chen holds 1,118,000 shares, representing 0.82% of the total [1] - The company confirms that this share reduction will not lead to a change in control or significantly impact its governance structure or future operations [1] Group 2 - Ruina Intelligent raised a total of 1.025 billion yuan from its initial public offering, with a net amount of 917 million yuan after deducting issuance costs [2] - The final net fundraising amount exceeded the original plan by 518 million yuan, which was initially set at 399 million yuan for various projects [2] - The company distributed a cash dividend of 8 yuan per 10 shares for the 2022 fiscal year, totaling 59.51 million yuan, and also increased the share capital by 8 shares for every 10 shares held [2]

Core Viewpoint - The stock of Shenguan Medical (300888.SZ) is currently in a state of decline, closing at 38.08 yuan with a drop of 3.57%, indicating it is below its initial public offering price [1] Group 1: Company Overview - Shenguan Medical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on September 17, 2020, with an issuance of 50 million shares at a price of 74.30 yuan per share [1] - The total funds raised by Shenguan Medical amounted to 3.715 billion yuan, with a net amount of 3.559 billion yuan after deducting issuance costs, which was 2.133 billion yuan more than the original plan [1] Group 2: Fund Utilization - The company initially planned to raise 1.426 billion yuan for projects including high-end dressing production line construction, marketing network development, research and development center establishment, and digital management system project [1] Group 3: Underwriting and Fees - The underwriting institution for Shenguan Medical's IPO was China International Capital Corporation, with representatives Shen Lulu and Wang Haonan, and the total issuance cost was 156 million yuan, of which the underwriting fee was 123 million yuan [1] Group 4: Dividend Distribution - On May 27, 2023, Shenguan Medical announced a cash dividend of 19.00 yuan (including tax) for every 10 shares, along with a capital increase of 4 shares for every 10 shares, based on a total of 419,737,649 shares after deducting repurchased shares [1]

Group 1 - The core point of the article is that Weiyuan Co., Ltd. (维远股份) has announced that its performance for 2025 is expected to be below expectations due to factors such as declining product prices, leading to a projected net loss for the year [1] - Weiyuan Co., Ltd. was listed on the Shanghai Stock Exchange on September 15, 2021, with an initial public offering of 138 million shares at a price of 29.56 yuan per share, and the stock is currently trading below its initial offering price [1] - The total amount raised from the initial public offering was 4.065 billion yuan, with a net amount of 3.88 billion yuan after deducting issuance costs, which was 2 billion yuan more than originally planned [1] Group 2 - In 2024, Weiyuan Co., Ltd. achieved an operating revenue of 9.522 billion yuan, representing a year-on-year increase of 35.06%, while the net profit attributable to shareholders decreased by 42.62% to 56.59 million yuan [2] - The company's net profit after deducting non-recurring gains and losses was 45.31 million yuan, down 36.85% year-on-year, while the net cash flow from operating activities increased by 49.52% to 918 million yuan [2]